Skip to main content
Equibles

MORGAN STANLEY

Position in GPCR — Structure Therapeutics Inc.

CIK 895421 NEW YORK, NY
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$150,632,366
+$39,509,342 QoQ
Shares Held
2,806,640
+21.7% QoQ
Ownership
3.94%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 190 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. GPCR ranks #19 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in GPCR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $150,632,366 2,806,640
2026-03-31 $111,123,024 2,305,457
2025-12-31 $145,208,850 2,087,834
2025-09-30 $16,176,748 577,741
2025-06-30 $19,025,751 917,346
2025-03-31 $11,986,115 692,439
2024-12-31 $10,500,210 387,176
2024-09-30 $7,131,507 162,486
2024-06-30 $5,195,066 132,291
2024-03-31 $12,585,107 293,633
2023-12-31 $11,700,929 287,069
2023-09-30 $1,200,700 23,814
2023-03-31 $261 11